CAMK2A and ischemic stroke: Due to its central role in regulating physiological and pathological glutamate signaling directly downstream of NMDA receptors, CaMKIIα emerged as a promising target for neuroprotective treatments for ischemic stroke and potentially other diseases characterized by glutamate and Ca2+ dysregulation [21,24,26].